SPECIAL NOTICE
99 -- Request for Information (RFI) for NCI's FFRDC: Draft Section M Small Business Participation Language
- Notice Date
- 1/28/2022 11:56:34 AM
- Notice Type
- Special Notice
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- NIH NCI ROCKVILLE MD 20852 USA
- ZIP Code
- 20852
- Solicitation Number
- REQUEST-FOR-INFORMATION-NOTICE_HHS-NIH-NCI-RFI-MOSB-75N91020R00062-22
- Response Due
- 2/14/2022 1:00:00 PM
- Archive Date
- 03/14/2022
- Point of Contact
- Lisa Coleman, Donald Mills
- E-Mail Address
-
FNLCR_ACQinfo@mail.nih.gov, FNLCR_ACQinfo@mail.nih.gov
(FNLCR_ACQinfo@mail.nih.gov, FNLCR_ACQinfo@mail.nih.gov)
- Description
- Notice Type: Special Notice�� Notice Number:��HHS-NIH-NCI-RFI-MOSB-75N91020R00062-22� Synopsis: Request for Information (RFI) for the National Cancer Institute�s Federally Funded Research and Development Center (FFRDC)/Frederick National Laboratory for Cancer Research (FNLCR)�� BACKGROUND:� The National Cancer Institute (NCI) is requesting information from�all parties who may be�interested�in�the�re-competition�of the NCI�s�FFRDC.� The FFRDC provides rapid response capabilities and one-of-a-kind resources for the biomedical research community within NCI, NIH and other Federal Agencies.�Located in Frederick, MD, the NCI�s FFRDC is a Government-Owned Contractor-Operated (GOCO) research facility with a unique array of�research support and�advanced technologies,�whose purpose is to bridge the gaps�from�discovery�to�healthcare delivery;�to�accelerate�the development of new technologies and prototype treatments for patients; and�to�pave�the way for new advances to enter clinical trials for testing, approval, and delivery to patients via the commercial sector.� Entities authorized to operate, manage, or administer an FFRDC include:�a university,�a�consortium of universities, other not-for-profit or nonprofit organizations,�industrial firms�as autonomous organizations�(identified�separately from any�parent organization), or�industry/academia partnerships.�� For more information, please refer to�the website at�http://frederick.cancer.gov/.� DISCLAIMER TO PROSPECTIVE RESPONDENTS:�� THIS IS A�REQUEST FOR INFORMATION (RFI).��This is�NOT�a solicitation for proposals,�capability statements,�proposal abstracts, or quotations. The purpose of this RFI is to obtain knowledge and information for project planning purposes.�Interested parties are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this RFI; all costs associated with responding to this RFI will be solely at the interested party�s expense.�Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.�Those not responding to this RFI�are�not prohibited from�participation in any future RFP, if any. If a solicitation is released, it will be synopsized on�Sam.gov�(SAM)�in�addition�to�the NCI Office of Acquisition�s website under the�FNLCR Acquisition�Portal�at��https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/acquisition-noticesInformation posted to�Beta SAM�takes�precedence over information provided�elsewhere�and serves as the Government�s official government-wide point of entry (GPE).� �INFORMATION FROM INDUSTRY:�� Interested organizations are asked to provide input�that addresses all of the following questions related to the attached�Draft Section M Small Business Participation Language.�� Does the solicitation provide sufficient information for offerors to develop a robust small business outreach/participation plan that could be demonstrated in a proposal and evaluated as outlined in sections M.3.1.�through M.3.7? ?If not, what information would be necessary?� Can the offeror provide documentation of positive past performance in meeting small business subcontracting goals in an R&D environment?�� Can the offeror demonstrate past examples of meeting/exceeding small business goals?�� Does your organization have any existing partnerships with small businesses in an R&D and/or FFRDC environment that would allow you to propose a robust small business outreach?� Can your organization document any experience in developing and maintaining a robust small business outreach program for an R&D contract?� � � �2. DESCRIPTION OF INFORMATION REQUESTED:� � � � � Interested parties�should�provide�their respective answers below�each stated question.�� You must�submit your response�electronically�in a�MS Word�or�Adobe Portable Document Format�(PDF) in�no more than�ten�(10) single-spaced, single-sided�pages,�with standard 1��margins, and�12-point Times New Roman font.��Any pages exceeding the page limitation designated herein�will not�be reviewed.��The due date for the submission of responses to�this�RFI is�4:00 PM EDT�on February�14,�2022.��The RFI response�must�be sent via e-mail to�FNLCR_ACQinfo@nih.gov�with subject line �Response to�RFI Notice Number:�HHS-NIH-NCI-RFI-MOSB-75N91020R00062-22�.� Any questions related to this RFI should be directed to�FNLCR_ACQinfo@nih.gov�with the subject line entitled:��Question�to�RFI Notice Number:�HHS-NIH-NCI-RFI-MOSB-75N91020R00062-22�.�� ATTACHMENTS� Attachment 1-�Draft Section M Small Business Participation Language� CONFIDENTIALITY:�� No proprietary, classified, confidential, or sensitive information should be included in your response.�The Government reserves the right to use information provided by respondents for any purpose(s)�it�deems necessary and legally appropriate.�
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/49d97d54c7194289b2999971191f55ea/view)
- Record
- SN06227308-F 20220130/220129201522 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |